Interstitial Lung Disease Trial, Recruiting (NCT06557343)

Interstitial Lung Disease Trial, Recruiting NCT06557343 Sponsor: NHS Lothian Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06557343 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You have previously had radiotherapy to the chest area and are showing signs of radiation pneumonitis (a type of lung inflammation that can develop one to four months after radiotherapy, with symptoms such as breathlessness — especially when active — a cough, or chest discomfort lasting several weeks; a chest X-ray may or may not show changes)
You are able to walk around independently, do not need extra oxygen to breathe, have a blood oxygen level above 92% when breathing normal air, and are in a stable enough condition to safely have a bronchoscopy (a procedure to look inside the airways)
You are willing and likely able to have a bronchoscopy, meaning you can lie flat without breathing difficulties, and you are able to give consent to take part in this study

Who may not be able to join:

You are not able to have a bronchoscopy for any reason — for example, you have not tolerated one before, you cannot lie flat, or your blood oxygen level is 92% or below when breathing normal air
You currently need to be in hospital or require extra oxygen to breathe
You have tested positive for COVID-19 within the six weeks before joining the trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06557343

Sponsor: NHS Lothian

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

More information: https://clinicaltrials.gov/study/NCT06557343

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You have previously had radiotherapy to the chest area and are showing signs of radiation pneumonitis (a type of lung inflammation that can develop one to four months after radiotherapy, with symptoms such as breathlessness — especially when active — a cough, or chest discomfort lasting several weeks; a chest X-ray may or may not show changes)
You are able to walk around independently, do not need extra oxygen to breathe, have a blood oxygen level above 92% when breathing normal air, and are in a stable enough condition to safely have a bronchoscopy (a procedure to look inside the airways)
You are willing and likely able to have a bronchoscopy, meaning you can lie flat without breathing difficulties, and you are able to give consent to take part in this study

Who may not be able to join:

You are not able to have a bronchoscopy for any reason — for example, you have not tolerated one before, you cannot lie flat, or your blood oxygen level is 92% or below when breathing normal air
You currently need to be in hospital or require extra oxygen to breathe
You have tested positive for COVID-19 within the six weeks before joining the trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NHS Lothian

Registry

ClinicalTrials.gov

Start date

25 October 2024

Est. completion

1 October 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Successful creation of dataset

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov